ptTheragnostic aims to achieve more effective, individualized radiation therapy for cancer patients. It will offer a reliable method for the stratification of patients that are predicted to benefit from proton therapy compared to photon therapy. The strategy of the company is to develop, sell and provide services, which support radiation oncologists in making treatment decisions on individual cancer patients.